Treatment for Hepatocellular Carcinoma: Recent Advances, Current Concepts and Future Trends
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 3460
Special Issue Editor
Interests: immune-oncology; upper gastro-intestinal cancers; hepato-biliary cancers; pancreas cancer; esophagus cancer; gastric cancer; neuro-endocrine tumors; rare cancers; histopathology; precision medicine; targeted treatments; clinical trials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancer cases, which is the fourth leading cause of cancer-related death globally. HCC is associated with chronic inflammation with cirrhosis caused by hepatitis B and C virus, alcohol or fatty liver disease, and many cases are potentially preventable. Earlier detection and improvements in diagnosis, staging, molecular classification, surgery, non-surgical ablative procedures and management of co-morbidities are among measures to improve the outcome. New knowledge of the molecular basis of the disease has recently led to development of several targeted treatments and immunotherapy with an impact on the prognosis of patients with advanced disease. With this Special Issue, we hope to encourage submissions that discuss the current state of the art, address ongoing knowledge gaps, and focus on ongoing controversies related to treatment of HCC.
Prof. Dr. Morten Ladekarl
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HCC diagnosis
- HCC state of the art
- HCC oncology
- HCC radiology
- HCC epidemiology
- HCC molecular biology